HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elastin metabolism of the infrarenal aorta.

Abstract
Aortic tissue elastase and alpha 1-antitrypsin were assayed in 67 patients with different types of infrarenal aortic disease; occlusive disease, elective abdominal aortic aneurysms (AAAs), multiple aneurysms, and ruptured aneurysms. Elastase modified by alpha 1-antitrypsin (elastase/alpha 1-antitrypsin) increased significantly as the type of aortic disease changed from occlusive to aneurysmal disease. Aortic elastase was significantly higher in patients with AAAs, multiple aneurysms, and ruptured AAAs compared with occlusive disease. The alpha 1-antitrypsin, was significantly lower in patients with multiple aneurysms and ruptured AAAs. These data suggest that the ratio between elastase and its major serum inhibitor, alpha 1-antitrypsin, is significantly altered in the aortic wall in different types of infrarenal aortic disease. In addition, the ratio between these two enzyme systems changes in favor of more proteolytic activity as the type of infrarenal disease changes from occlusive to aneurysmal.
AuthorsJ R Cohen, C Mandell, J B Chang, L Wise
JournalJournal of vascular surgery (J Vasc Surg) Vol. 7 Issue 2 Pg. 210-4 (Feb 1988) ISSN: 0741-5214 [Print] United States
PMID3123716 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • alpha 1-Antitrypsin
  • Elastin
  • Pancreatic Elastase
Topics
  • Aorta, Abdominal (enzymology, metabolism)
  • Aortic Aneurysm (enzymology, metabolism)
  • Aortic Diseases (enzymology, metabolism)
  • Aortic Rupture (enzymology, metabolism)
  • Arterial Occlusive Diseases (enzymology, metabolism)
  • Elastin (metabolism)
  • Humans
  • Immunodiffusion
  • Pancreatic Elastase (analysis)
  • alpha 1-Antitrypsin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: